71 related articles for article (PubMed ID: 20619801)
1. Conversion between sirolimus and everolimus in heart transplant recipients.
Wert TJ; Heeney S; Morrison M
Clin Transplant; 2023 Nov; 37(11):e15102. PubMed ID: 37589884
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and clinical characteristics of oral lesions in heart transplant patients induced by sirolimus and everolimus: a systematic review and meta-analysis on a global scale.
Moura AEO; Besseler MO; Pérez-de-Oliveira ME; Normando AGC; Neves ILI; Neves RS; Vargas PA; Azeka E; Santos-Silva AR; Montano TCP
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Jan; 137(1):37-52. PubMed ID: 37925270
[TBL] [Abstract][Full Text] [Related]
3. Safety and Effectiveness of Medical Therapy and Surgical Intervention for Renal Angiomyolipoma Associated With Tuberous Sclerosis Complex.
Wang Z; Zhang W; Fan Y; Zhang X
Cancer Control; 2022; 29():10732748221140266. PubMed ID: 36471546
[TBL] [Abstract][Full Text] [Related]
4. Accuracy evaluation of automated electrochemiluminescence immunoassay for everolimus and sirolimus compared to liquid chromatography-tandem mass spectrometry.
Lee EJ; Kim HK; Ahn S; Lee W; Kim HS; Chun S; Min WK
J Clin Lab Anal; 2019 Sep; 33(7):e22941. PubMed ID: 31197901
[TBL] [Abstract][Full Text] [Related]
5. Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy.
Helmschrott M; Rivinius R; Bruckner T; Katus HA; Doesch AO
Drug Des Devel Ther; 2017; 11():1673-1680. PubMed ID: 28652705
[TBL] [Abstract][Full Text] [Related]
6. Twelve-month efficacy and safety of the conversion to everolimus in maintenance heart transplant recipients.
Manito N; Delgado JF; Crespo-Leiro MG; Arizón JM; Segovia J; González-Vílchez F; Mirabet S; Lage E; Pascual-Figal D; Díaz B; Palomo J; Rábago G; Sanz M; Blasco T; Roig E
World J Transplant; 2015 Dec; 5(4):310-9. PubMed ID: 26722659
[TBL] [Abstract][Full Text] [Related]
7. Everolimus and sirolimus in transplantation-related but different.
Klawitter J; Nashan B; Christians U
Expert Opin Drug Saf; 2015 Jul; 14(7):1055-70. PubMed ID: 25912929
[TBL] [Abstract][Full Text] [Related]
8. Everolimus in heart transplantation: an update.
Hirt SW; Bara C; Barten MJ; Deuse T; Doesch AO; Kaczmarek I; Schulz U; Stypmann J; Haneya A; Lehmkuhl HB
J Transplant; 2013; 2013():683964. PubMed ID: 24382994
[TBL] [Abstract][Full Text] [Related]
9. Kaposi's sarcoma in renal transplant recipients--the impact of proliferation signal inhibitors.
Campistol JM; Schena FP
Nephrol Dial Transplant; 2007 May; 22 Suppl 1():i17-22. PubMed ID: 17456614
[TBL] [Abstract][Full Text] [Related]
10. Clinical recommendations for the use of everolimus in heart transplantation.
Manito N; Delgado JF; Crespo-Leiro MG; González-Vílchez F; Almenar L; Arizón JM; Díaz B; Fernández-Yáñez J; Mirabet S; Palomo J; Rodríguez Lambert JL; Roig E; Segovia J
Transplant Rev (Orlando); 2010 Jul; 24(3):129-42. PubMed ID: 20619801
[TBL] [Abstract][Full Text] [Related]
11. Multidisciplinary insights on clinical guidance for the use of proliferation signal inhibitors in heart transplantation.
Zuckermann A; Manito N; Epailly E; Fiane A; Bara C; Delgado JF; Lehmkuhl H; Ross H; Eisen H; Chapman J; Valantine H
J Heart Lung Transplant; 2008 Feb; 27(2):141-9. PubMed ID: 18267219
[TBL] [Abstract][Full Text] [Related]
12. Everolimus in clinical practice--renal transplantation.
Pascual J
Nephrol Dial Transplant; 2006 Jul; 21 Suppl 3():iii18-23. PubMed ID: 16815852
[TBL] [Abstract][Full Text] [Related]
13. Clinical experience with Certican (everolimus) in de novo heart transplant patients at the Deutsches Herzzentrum Berlin.
Lehmkuhl H; Hetzer R
J Heart Lung Transplant; 2005 Apr; 24(4 Suppl):S201-5; discussion S210-1. PubMed ID: 15774323
[TBL] [Abstract][Full Text] [Related]
14. Comparison of sirolimus and everolimus in their effects on blood lipid profiles and haematological parameters in heart transplant recipients.
Tenderich G; Fuchs U; Zittermann A; Muckelbauer R; Berthold HK; Koerfer R
Clin Transplant; 2007; 21(4):536-43. PubMed ID: 17645716
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
